Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders

 
 

MiddleBrook Pharmaceuticals, Inc. (MBRKQ) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $0.07 Metrics
OS: 86.5 M
Market cap: $6.06 M
Net cash: $10.9 M $0.13 per share
EV:

 
TTM Valuation
EBITDA ($62.1) M
EBIT ($67.6) M
EPS ($0.78)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-09Dec-31-08Dec-31-07Dec-31-06Dec-31-05Dec-31-04Dec-31-03Dec-31-02
Revenues14.88.810.54.816.811.43.610.9
            Revenue growth67.7%-15.4%117.4%-71.4%48.3%213.3%-66.6%105.0%
Cost of goods sold2.31.62.60.90.60.216.621.7
Gross profit12.67.27.93.916.311.2-13.0-10.9
            Gross margin84.8%81.5%75.4%81.3%96.7%98.5%-357.8%-100.0%
Selling, general and administrative69.924.426.021.310.512.26.43.3
EBIT-62.6-36.2-40.1-43.4-34.0-34.7-19.4-14.2
            EBIT margin-421.4%-409.6%-383.7%-901.2%-201.6%-305.3%-535.1%-130.6%
Pre-tax income-62.2-42.2-42.4-42.0-33.0-34.0-21.0-14.1
Income taxes0.2-0.20.00.00.00.00.00.0
            Tax rate 0.4%0.0%0.0%0.0%0.0%0.0%0.0%
Net income-62.3-42.1-42.4-42.0-33.0-34.0-42.1-14.2
            Net margin-419.9%-475.4%-405.6%-872.9%-195.8%-299.4%-1161.2%-130.8%
 
Diluted EPS($0.72)($0.65)($0.97)($1.38)($1.20)($1.50)($7.58)($16.37)
Shares outstanding (diluted)86.565.243.830.527.422.75.60.9
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy